to Translate and Validate the TOPAS TORONTO PSORIATIC SCREENING QUESTIONNAIRE)Into Spanish
NCT01891903 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2013-07-03
Summary
TO TRANSALETE AND VALIDATE DE TORONTO PSORIATIC ARTHRITIS SECREENING QUESTIONAIRE INTO SPANISH
Conditions
Sponsors & Collaborators
-
Reumatologia Integral LTDA
lead OTHER
Principal Investigators
-
Daniel Fernandez, rheumatolo · hospital san ignasio
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-05-31
- Primary Completion
- 2013-08-31
- Completion
- 2013-09-30
Countries
- Colombia
More Related Trials
-
An Efficacy and Safety of CNTO 1959 (Guselkumab) in Participants With Moderate to Severe Plaque-type Psoriasis
NCT02325219 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis
NCT06176508 ·Status: RECRUITING ·Phase: PHASE2
-
Cytokine Expression in Psoriasis Patients with and Without Joint Involvement
NCT05307809 ·Status: RECRUITING ·Phase: NA
-
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
NCT01925768 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess How Well Certolizumab Pegol Works in Patients With Moderate to Severe Plaque Psoriasis as Part of Routine Clinical Practice
NCT04053881 ·Status: COMPLETED
-
Modifying PEST for Psoriatic Arthritis Screening
NCT06382051 ·Status: RECRUITING ·Phase: NA
-
Special Drug Use-results Survey to Evaluate Safety and Efficacy of Cosentyx in Pediatric Patients With PsV, PsA, or GPP
NCT05215561 ·Status: COMPLETED
-
A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis
NCT01519089 ·Status: COMPLETED ·Phase: PHASE3
-
Mechanism of Action Study for Psoriasis
NCT00932113 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the Safety, Tolerability, Pharmacokinetics (What the Body Does to the Drug), and Pharmacodynamics (What the Drug Does to the Body) of CNTO 1959 Following a Single Subcutaneous (Under the Skin) Administration in Japanese Participants With Moderate to Severe Plaque Psoriasis
NCT01484587 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type Psoriasis
NCT01988103 ·Status: COMPLETED ·Phase: PHASE2
-
Imaging Treat-to-target Strategy vs Conventional Treat-to-target Strategy in Psoriatic Arthritis
NCT05291819 ·Status: RECRUITING ·Phase: NA
-
To Observe the Impacts of Anti-Tumor Necrosis Factor (TNF) Effectiveness on Improvement in Work Place and Household Productivity for Patients With Psoriatic Arthritis (PsA)
NCT02028169 ·Status: COMPLETED
-
Multiple Dose Escalation Study In Medically Stable Subjects With Psoriasis
NCT01736696 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis
NCT03090100 ·Status: COMPLETED ·Phase: PHASE3
-
An Efficacy and Safety Study of CNTO1959 (Guselkumab) in the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis
NCT02343744 ·Status: COMPLETED ·Phase: PHASE3
-
A Worldwide Survey on the Understanding of Psoriatic Disease Among Patients With Psoriasis and Psoriatic Arthritis
NCT04614831 ·Status: COMPLETED
-
Study of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area Moderate Plaque Psoriasis
NCT06039189 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic Arthritis
NCT01860976 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability, Immunogenicity, and Pharmacodynamics (PD) of GSK2800528 in Healthy Subjects.
NCT01899755 ·Status: COMPLETED ·Phase: PHASE1
-
Prevalence and Incidence of Articular Symptoms and Signs Related to Psoriatic Arthritis in Patients With Psoriasis Severe or Moderate With Adalimumab Treatment
NCT01316224 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy, Safety, and Tolerability of NDI-034858 in Participants With Active Psoriatic Arthritis
NCT05153148 ·Status: COMPLETED ·Phase: PHASE2
-
CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry
NCT06100991 ·Status: RECRUITING
-
Phase 1 Study of CC-90005 in Healthy Subjects and Subjects With Moderate to Severe Plaque-type Psoriasis
NCT02502188 ·Status: TERMINATED ·Phase: PHASE1
-
Study to Assess the Efficacy, Safety and Tolerability of Secukinumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)
NCT01952015 ·Status: COMPLETED ·Phase: PHASE3